These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7371699)

  • 21. [Effects of labetalol on the response of arterial blood pressure to exercise in hypertensive patients].
    Wajngarten M; Antunes JE; Pereyra PL; Godoy M; Dauar D; Martinelli Filho M; Pereira Barretto AC; Pileggi F
    Arq Bras Cardiol; 1983 Jan; 40(1):65-7. PubMed ID: 6615264
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):795-8. PubMed ID: 10953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravenous labetalol in normotensive coronary patients. Effects on hemodynamics and myocardial metabolism].
    Ourbak P; Lardoux H; Pornin M; Bouziri S; Allal J; Duong TC; Sellier P; Maurice M
    Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1089-96. PubMed ID: 3929738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid reduction of blood pressure with acute oral labetalol.
    Davies AB; Bala Subramanian V; Gould B; Raftery EB
    Br J Clin Pharmacol; 1982 May; 13(5):705-10. PubMed ID: 7082539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Circulation; 1979 Dec; 60(6):1214-7. PubMed ID: 40708
    [No Abstract]   [Full Text] [Related]  

  • 27. Haemodynamic effects of intravenous labetalol in hypertensive patients with obstructive coronary heart disease complicated by acute myocardial infarction of recent origin.
    Mulac KD; Meryn S
    Eur Heart J; 1983 Jun; 4(6):398-405. PubMed ID: 6617686
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of labetalol on arterial blood gas data, pulmonary haemodynamics and pulmonary shunting.
    De Hert SG; Heytens LG; De Jongh RG; Vercauteren MP; Boeckx EA; Adriaensen HF
    Intensive Care Med; 1988; 15(1):42-5. PubMed ID: 3230200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Labetalol: a new hypotensive agent in surgery of the middle ear. Peroperative hemodynamic study].
    Bertrand D; Guyon D; Maday T; Laxenaire MC
    Ann Fr Anesth Reanim; 1982; 1(4):387-92. PubMed ID: 7171135
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
    McNeil JJ; Anderson AE; Louis WJ; Morgan DJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
    Koch G
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic long-term effects of labetalol in essential hypertension.
    Lund-Johansen P
    Acta Med Scand Suppl; 1979; 625():54-8. PubMed ID: 285576
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood pressure response to labetalol in twice and three times daily administration during a 24-hour period.
    Mancia G; Pomidossi G; Parati G; Bertinieri G; Grassi G; Navone F; Ferrari A; Gregorini L; Zanchetti A
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):27S-35S. PubMed ID: 7093100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antihypertensive effects of labetalol in three types of hypertensive models of rats (author's transl)].
    Nakagawa Y; Takeda K; Sakurai H; Mitomi A; Imai S
    Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):435-45. PubMed ID: 7286847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):729-32. PubMed ID: 10951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of labetalol in hypertension during exercise and postural changes.
    Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.